These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32675634)
1. Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching. Kong H; Li N; Yang XC; Nie XL; Tian J; Wang DX Anesth Analg; 2021 Jan; 132(1):140-149. PubMed ID: 32675634 [TBL] [Abstract][Full Text] [Related]
2. Preoperative intravenous rehydration for patients with pheochromocytomas and paragangliomas: is it necessary? A propensity score matching analysis. Kong H; Yang JN; Tian J; Li N; Zhang YX; Ye PC; Li XY; Zhang Z BMC Anesthesiol; 2020 Nov; 20(1):294. PubMed ID: 33250060 [TBL] [Abstract][Full Text] [Related]
3. Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China. Yang Y; Zhang J; Fang L; Jia X; Zhang W Drug Des Devel Ther; 2022; 16():3599-3608. PubMed ID: 36262769 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients. Kim JH; Lee HC; Kim SJ; Lee KE; Jung KC Front Endocrinol (Lausanne); 2022; 13():816833. PubMed ID: 35282440 [TBL] [Abstract][Full Text] [Related]
5. Intraoperative hypotension is associated with increased postoperative complications in patients undergoing surgery for pheochromocytoma-paraganglioma: a retrospective cohort study. Li N; Kong H; Li SL; Zhu SN; Zhang Z; Wang DX BMC Anesthesiol; 2020 Jun; 20(1):147. PubMed ID: 32532209 [TBL] [Abstract][Full Text] [Related]
6. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY. Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Calatayud M; Hanzu F; Mora M; Vicente A; Blanco Carrera C; De Miguel Novoa P; López García MDC; Manjón-Miguélez L; Rodríguez de Vera P; Del Castillo Tous M; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Lamas C J Endocrinol Invest; 2023 Apr; 46(4):805-814. PubMed ID: 36323983 [TBL] [Abstract][Full Text] [Related]
7. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Brunaud L; Boutami M; Nguyen-Thi PL; Finnerty B; Germain A; Weryha G; Fahey TJ; Mirallie E; Bresler L; Zarnegar R Surgery; 2014 Dec; 156(6):1410-7; discussion1417-8. PubMed ID: 25456922 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas. Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Fernández-Ladreda MT; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Calatayud M J Hypertens; 2024 Feb; 42(2):252-259. PubMed ID: 37851004 [TBL] [Abstract][Full Text] [Related]
10. Perioperative hemodynamics and outcomes of patients on metyrosine undergoing resection of pheochromocytoma or paraganglioma. Butz JJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; McKenzie TJ; Schroeder DR; Martin DP; Sprung J Int J Surg; 2017 Oct; 46():1-6. PubMed ID: 28803996 [TBL] [Abstract][Full Text] [Related]
11. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas. Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783 [TBL] [Abstract][Full Text] [Related]
12. Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection. Weingarten TN; Welch TL; Moore TL; Walters GF; Whipple JL; Cavalcante A; Bancos I; Young WF; Gruber LM; Shah MZ; McKenzie TJ; Schroeder DR; Sprung J Urology; 2017 Feb; 100():131-138. PubMed ID: 27769919 [TBL] [Abstract][Full Text] [Related]
13. Predictors of hemodynamic instability during surgery for pheochromocytoma. Kiernan CM; Du L; Chen X; Broome JT; Shi C; Peters MF; Solorzano CC Ann Surg Oncol; 2014 Nov; 21(12):3865-71. PubMed ID: 24939623 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series. Deljou A; Kohlenberg JD; Weingarten TN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J BMC Anesthesiol; 2018 Nov; 18(1):158. PubMed ID: 30400849 [TBL] [Abstract][Full Text] [Related]
15. Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma. Fishbein L; Orlowski R; Cohen D J Clin Hypertens (Greenwich); 2013 Jun; 15(6):428-34. PubMed ID: 23730992 [TBL] [Abstract][Full Text] [Related]
16. Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. Agrawal R; Mishra SK; Bhatia E; Mishra A; Chand G; Agarwal G; Agarwal A; Verma AK World J Surg; 2014 Mar; 38(3):716-23. PubMed ID: 24233658 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas. Ruff SM; Ayabe RI; Malekzadeh P; Good ML; Wach MM; Gonzales MK; Tirosh A; Nilubol N; Pacak K; Kebebew E; Patel D J Surg Res; 2019 Nov; 243():1-7. PubMed ID: 31146085 [TBL] [Abstract][Full Text] [Related]
18. The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas. Ohmachi Y; Yamamoto M; Inaba Y; Makino S; Urai S; Matsumoto R; Bando H; Kanie K; Tsujimoto Y; Motomura Y; Sasaki Y; Oi-Yo Y; Yamamoto N; Suzuki M; Takahashi M; Iguchi G; Kanzawa M; Furukawa J; Shigemura K; Mizobuchi S; Ogawa W; Fukuoka H Endocrine; 2024 May; 84(2):694-703. PubMed ID: 38206436 [TBL] [Abstract][Full Text] [Related]
19. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Kinney MA; Warner ME; vanHeerden JA; Horlocker TT; Young WF; Schroeder DR; Maxson PM; Warner MA Anesth Analg; 2000 Nov; 91(5):1118-23. PubMed ID: 11049893 [TBL] [Abstract][Full Text] [Related]
20. Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary? Isaacs M; Lee P Clin Endocrinol (Oxf); 2017 Mar; 86(3):309-314. PubMed ID: 27864838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]